Brexafemme (Ibrexafungerp)
- Medicine Name: Brexafemme
- Generic Name: Ibrexafungerp
- Dosage Form & Strength: Tablets: 150 mg
- Manufactured By: Scynexis, Inc.
Brexafemme comes as an oral tablet that contains ibrexafungerp citrate, a triterpenoid antifungal agent. It is widely used in adults and post-menarchal pediatric females for:
- treatment of vulvovaginal candidiasis (VVC) or Vaginal Yeast Infection.
- reduction in the occurrence of recurrent vulvovaginal candidiasis (RVVC).
Recommended Dosage: Brexafemme tablets may be taken with or without food, exactly as your doctor tells you to take them. Take two tablets (300 mg) orally in the morning, and take two tablets (300) orally in the evening. If possible, the two doses (2 pills each) should be taken approximately 12 hours apart.
Treatment of VVC: The recommended dosage in adult and post-menarchal pediatric females is 300 mg (2 Brexafemme 150 mg tablets) administered around 12 hours apart (in the morning and in the evening) for one day, for a total daily dosage of 600 mg (4 Brexafemme 150 mg tablets).
Reduction in the Incidence of RVVC: The recommended dosage in adult and post-menarchal pediatric females is 300 mg (2 Brexafemme 150 mg tablets) administered around 12 hours apart (in the morning and in the evening) for a single day, for a total daily dosage of 600mg (four 150 mg pills of Brexafemme) monthly for 6 months.
- Brexafemme 150 mg is contraindicated in pregnancy because it may be responsible for causing fetal harm behalf of the data from animal reproductive studies.
- For females of reproductive age, verify that the respective patient is not pregnant before starting Ibrexafungerp 150 mg treatment. Reassessing the pregnancy status before each dose is recommended when this medicine is used monthly for six months for a reduction in the incidence of RVVC.
- Females of reproductive age should use appropriate contraception during the treatment of VVC (vulvovaginal candidiasis) and throughout the six-month treatment time span for a reduction in the incidence of RVVC with Brexafemme tablets and, for four days after the final dose.
- Patients should inform their healthcare specialist if they are on any other medicines as certain medicines can boost or scale down blood concentrations of Ibrexafungerp or Ibrexafungerp may boost or scale down blood concentrations of certain medicines.
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients ID Proof (issued by the government of India)
- A valid prescription from Doctor
- Import permit if applicable
- On Brexafemme availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
Indian Pharma Network is able to source the BREXAFEMME (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma Network offers its customers worldwide access to the best available treatment.
Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Brexafemme®?
Ibrexafungerp is a Generic Name for the trade name drug Brexafemme®.
What is the Manufacturer’s Name of Brexafemme®?
Brexafemme® is manufactured by Scynexis, Inc.
Is Brexafemme® approved by the FDA?
Yes, Brexafemme® is approved by the FDA. Date of first approval: June 1, 2021.
What is the dosage and form of Brexafemme® supplied?
Brexafemme® is supplied as Tablets: 150 mg for oral administration.
What are the most common side effects of Brexafemme®?
The most common side effects of Brexafemme® include nausea, loose stools, vomiting, dizziness, and stomach pain.
How much does Brexafemme® cost in India?
The medicine Brexafemme cost in India can vary. To buy this triterpenoid antifungal agent authentically, one can Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Brexafemme® Tablets?
Tablets of Brexafemme are packaged in polyvinyl/polyvinylidene chloride child-proof blister packs, four tablets per pack. Store at 20-25°C (68-77°F). Brief exposure to 15-30°C (59-86°F) is permitted.
Is it safe to buy Brexafemme® tablets online from India?
Yes, you can buy Brexafemme tablets online at the best price from the Indian Pharma Network (IPN) if the medicine has not been approved or is not available in your home country.
What are the Highlights of prescribing information for Brexafemme®?
Click Here to download full Brexafemme prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis. CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis.